Health, Economic Data Point to Better 2H20 for Cyclicals, Value

(COVID-19 remains a global crisis and we realize that many people need to keep up with COVID-19 developments, particularly since we are moving into the more critical stage ("restart economy"), so feel free to share our commentary with anyone who has interest.)

We received incrementally positive news Wednesday from Pfizer and BioNTech concerning a joint COVID-19 vaccine effort. Their first clinical trial shows positive results and specifically, those receiving this vaccine showed high levels ...

Finish reading this report for free

Enter your email and we’ll send the paywall-free link directly to your inbox

In addition to your unlocked report, you will receive our weekly market newsletter Fundstrat Snapshot, as well as occasional updates and offers from Fundstrat Direct. You can unsubscribe at any time. For more information, see our privacy policy.

Get unlimited access to Tom Lee’s Fundstrat research Subscribe
Already a member? Log in

More from the author

Disclosures (show)

Events

Trending tickers in our research